Annual Operating Profit
-$65.54 M
+$13.51 M+17.09%
December 31, 2023
Summary
- As of March 5, 2025, URGN annual operating income is -$65.54 million, with the most recent change of +$13.51 million (+17.09%) on December 31, 2023.
- During the last 3 years, URGN annual operating profit has risen by +$61.20 million (+48.29%).
- URGN annual operating profit is now -8312.53% below its all-time high of $798.00 thousand, reached on December 31, 2016.
Performance
URGN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$17.55 M
+$8.29 M+32.10%
September 30, 2024
Summary
- As of March 5, 2025, URGN quarterly operating income is -$17.55 million, with the most recent change of +$8.29 million (+32.10%) on September 30, 2024.
- Over the past year, URGN quarterly operating profit has stayed the same.
- URGN quarterly operating profit is now -226.21% below its all-time high of $13.90 million, reached on December 31, 2016.
Performance
URGN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$83.73 M
-$4.04 M-5.08%
September 30, 2024
Summary
- As of March 5, 2025, URGN TTM operating income is -$83.73 million, with the most recent change of -$4.04 million (-5.08%) on September 30, 2024.
- Over the past year, URGN TTM operating profit has stayed the same.
- URGN TTM operating profit is now -2004.75% below its all-time high of $4.40 million, reached on December 31, 2016.
Performance
URGN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
URGN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.1% | 0.0% | 0.0% |
| 3 y3 years | +48.3% | +25.1% | +16.0% |
| 5 y5 years | +15.1% | +25.2% | +23.5% |
URGN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.0% | -30.0% | +32.1% | -27.8% | +9.3% |
| 5 y | 5-year | at high | +48.3% | -30.0% | +56.0% | -27.8% | +39.9% |
| alltime | all time | -8312.5% | +48.3% | -226.2% | +56.0% | -2004.8% | +39.9% |
UroGen Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.55 M(-32.1%) | -$83.73 M(+5.1%) |
| Jun 2024 | - | -$25.84 M(+0.4%) | -$79.69 M(+15.1%) |
| Mar 2024 | - | -$25.74 M(+76.2%) | -$69.23 M(+5.6%) |
| Dec 2023 | -$65.54 M(-17.1%) | -$14.61 M(+8.2%) | -$65.54 M(-8.0%) |
| Sep 2023 | - | -$13.50 M(-12.2%) | -$71.21 M(-6.1%) |
| Jun 2023 | - | -$15.38 M(-30.2%) | -$75.80 M(-4.2%) |
| Mar 2023 | - | -$22.05 M(+8.7%) | -$79.13 M(+0.1%) |
| Dec 2022 | -$79.04 M(-14.4%) | -$20.28 M(+12.1%) | -$79.04 M(+0.5%) |
| Sep 2022 | - | -$18.09 M(-3.4%) | -$78.67 M(-6.4%) |
| Jun 2022 | - | -$18.71 M(-14.8%) | -$84.03 M(-4.7%) |
| Mar 2022 | - | -$21.96 M(+10.3%) | -$88.14 M(-4.5%) |
| Dec 2021 | -$92.29 M(-27.2%) | -$19.91 M(-15.0%) | -$92.29 M(-7.4%) |
| Sep 2021 | - | -$23.44 M(+2.7%) | -$99.63 M(-5.4%) |
| Jun 2021 | - | -$22.82 M(-12.6%) | -$105.31 M(-7.9%) |
| Mar 2021 | - | -$26.11 M(-4.2%) | -$114.29 M(-9.8%) |
| Dec 2020 | -$126.74 M | -$27.25 M(-6.4%) | -$126.74 M(-9.0%) |
| Sep 2020 | - | -$29.12 M(-8.4%) | -$139.32 M(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$31.80 M(-17.5%) | -$133.65 M(+6.4%) |
| Mar 2020 | - | -$38.56 M(-3.2%) | -$125.61 M(+14.7%) |
| Dec 2019 | -$109.48 M(+41.8%) | -$39.84 M(+69.9%) | -$109.48 M(+16.9%) |
| Sep 2019 | - | -$23.45 M(-1.3%) | -$93.66 M(+2.6%) |
| Jun 2019 | - | -$23.75 M(+5.9%) | -$91.29 M(+6.2%) |
| Mar 2019 | - | -$22.43 M(-6.6%) | -$85.97 M(+11.4%) |
| Dec 2018 | -$77.18 M(+286.9%) | -$24.02 M(+13.9%) | -$77.18 M(+21.9%) |
| Sep 2018 | - | -$21.09 M(+14.4%) | -$63.32 M(+48.9%) |
| Jun 2018 | - | -$18.43 M(+35.1%) | -$42.53 M(+41.5%) |
| Mar 2018 | - | -$13.64 M(+34.3%) | -$30.05 M(+50.6%) |
| Dec 2017 | -$19.95 M(-2600.0%) | -$10.16 M(+3252.5%) | -$19.95 M(-585.5%) |
| Sep 2017 | - | -$303.00 K(-94.9%) | $4.11 M(-342.0%) |
| Jun 2017 | - | -$5.95 M(+68.2%) | -$1.70 M(-297.9%) |
| Mar 2017 | - | -$3.54 M(-125.5%) | $858.00 K(-80.5%) |
| Dec 2016 | $798.00 K(-106.4%) | $13.90 M(-327.5%) | $4.40 M(-146.2%) |
| Sep 2016 | - | -$6.11 M(+80.0%) | -$9.51 M(+180.0%) |
| Jun 2016 | - | -$3.40 M | -$3.40 M |
| Dec 2015 | -$12.41 M | - | - |
FAQ
- What is UroGen Pharma annual operating income?
- What is the all time high annual operating profit for UroGen Pharma?
- What is UroGen Pharma annual operating profit year-on-year change?
- What is UroGen Pharma quarterly operating income?
- What is the all time high quarterly operating profit for UroGen Pharma?
- What is UroGen Pharma quarterly operating profit year-on-year change?
- What is UroGen Pharma TTM operating income?
- What is the all time high TTM operating profit for UroGen Pharma?
- What is UroGen Pharma TTM operating profit year-on-year change?
What is UroGen Pharma annual operating income?
The current annual operating profit of URGN is -$65.54 M
What is the all time high annual operating profit for UroGen Pharma?
UroGen Pharma all-time high annual operating income is $798.00 K
What is UroGen Pharma annual operating profit year-on-year change?
Over the past year, URGN annual operating income has changed by +$13.51 M (+17.09%)
What is UroGen Pharma quarterly operating income?
The current quarterly operating profit of URGN is -$17.55 M
What is the all time high quarterly operating profit for UroGen Pharma?
UroGen Pharma all-time high quarterly operating income is $13.90 M
What is UroGen Pharma quarterly operating profit year-on-year change?
Over the past year, URGN quarterly operating income has changed by $0.00 (0.00%)
What is UroGen Pharma TTM operating income?
The current TTM operating profit of URGN is -$83.73 M
What is the all time high TTM operating profit for UroGen Pharma?
UroGen Pharma all-time high TTM operating income is $4.40 M
What is UroGen Pharma TTM operating profit year-on-year change?
Over the past year, URGN TTM operating income has changed by $0.00 (0.00%)